Penumbra, Inc. (PEN) Earnings Call Analysis
NYSE · Healthcare · Medical Devices
Earnings Reports
-
Penumbra (PEN) Q3 2025: U.S. Embolization Surges 29%, Unlocking Dual-Engine Growth
November 06, 2025
-
Penumbra (PEN) Q2 2025: U.S. Thrombectomy Jumps 22% as Dedicated Sales Teams Fuel Segment Focus
July 30, 2025
-
Penumbra (PEN) Q1 2025: U.S. Thrombectomy Grows 25% as CAVT Drives Market Share Gains
July 04, 2025